
### [NCIT:C36101](http://purl.obolibrary.org/obo/NCIT_C36101)
**Label:** BRCA2 Syndrome

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 52.53%
- [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) 51.32%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 50.57%
- [NCIT:C3709](http://purl.obolibrary.org/obo/NCIT_C3709) (Epithelial Neoplasm) 49.26%
- [NCIT:C2991](http://purl.obolibrary.org/obo/NCIT_C2991) (Disease or Disorder) 48.19%
- [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) 45.30%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 44.31%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 43.43%
- [NCIT:C3224](http://purl.obolibrary.org/obo/NCIT_C3224) (Melanoma) 40.36%
- [NCIT:C3224](http://purl.obolibrary.org/obo/NCIT_C3224) (Melanoma) and (not ([NCIT:C39596](http://purl.obolibrary.org/obo/NCIT_C39596) (CCND2 Gene))) 40.36%
- [NCIT:C3224](http://purl.obolibrary.org/obo/NCIT_C3224) (Melanoma) and (not ([NCIT:C39594](http://purl.obolibrary.org/obo/NCIT_C39594) (Skin Rash))) 40.36%
- [NCIT:C3224](http://purl.obolibrary.org/obo/NCIT_C3224) (Melanoma) and (not ([NCIT:C39593](http://purl.obolibrary.org/obo/NCIT_C39593) (Peripheral Blood Involvement))) 40.36%
- [NCIT:C3224](http://purl.obolibrary.org/obo/NCIT_C3224) (Melanoma) and (not ([NCIT:C39589](http://purl.obolibrary.org/obo/NCIT_C39589) (Angioinvasion))) 40.36%
- [NCIT:C3224](http://purl.obolibrary.org/obo/NCIT_C3224) (Melanoma) and (not ([NCIT:C39588](http://purl.obolibrary.org/obo/NCIT_C39588) (Serum Soluble Fas Ligand Level Increased))) 40.36%
- [NCIT:C3224](http://purl.obolibrary.org/obo/NCIT_C3224) (Melanoma) and (not ([NCIT:C39586](http://purl.obolibrary.org/obo/NCIT_C39586) (T-Cell Large Granular Lymphocyte Leukemia Expressing the T-Cell Receptor Gamma-Delta))) 40.36%


